|
RNASEN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.725980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.427900E-02 |
| Normal-vs-Stage2 |
6.167800E-01 |
| Normal-vs-Stage3 |
5.900600E-01 |
| Normal-vs-Stage4 |
1.609650E-02 |
| Stage1-vs-Stage2 |
7.264800E-01 |
| Stage1-vs-Stage3 |
6.752200E-01 |
| Stage1-vs-Stage4 |
4.169200E-01 |
| Stage2-vs-Stage3 |
9.885400E-01 |
| Stage2-vs-Stage4 |
3.409000E-01 |
| Stage3-vs-Stage4 |
3.366800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.614020E-01 |
| Normal-vs-AfricanAmerican |
1.946230E-01 |
| Normal-vs-Asian |
2.530200E-01 |
| Caucasian-vs-AfricanAmerican |
8.327400E-01 |
| Caucasian-vs-Asian |
8.304800E-01 |
| AfricanAmerican-vs-Asian |
8.735800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.504200E-03 |
| Normal-vs-Female |
1.225990E-01 |
| Male-vs-Female |
8.200200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.530400E-01 |
| Normal-vs-Extreme_Weight |
1.972360E-02 |
| Normal-vs-Obese |
8.290200E-01 |
| Normal-vs-Extreme_Obese |
6.551500E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.975600E-01 |
| Normal_Weight-vs-Obese |
3.853600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.397780E-01 |
| Extreme_Weight-vs-Obese |
7.594400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.576400E-01 |
| Obese-vs-Extreme_Obese |
3.510300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.226200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.547000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.193500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.395450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.852200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.002360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.857600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.000760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.188800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.057000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.050400E-02 |
| Normal-VS-Type2 PRCC |
8.407900E-02 |
| Normal-VS-KIRP CIMP |
1.799200E-01 |
| Normal-VS-Unclassified PRCC |
3.251400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.502000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.000200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.072500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.480400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.694100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.730190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.997300E-03 |
| Normal-vs-N1 |
9.518000E-01 |
| Normal-vs-N2 |
5.142300E-02 |
| N0-vs-N1 |
8.558400E-02 |
| N0-vs-N2 |
8.264600E-01 |
| N1-vs-N2 |
3.298600E-01 |
|
|
